All In Biotech

Drug Trial Radar · NCT02299414

Chronic Hypertension and Pregnancy (CHAP) Project

A Pragmatic Multicenter Randomized Clinical Trial (RCT) of Antihypertensive Therapy for Mild Chronic Hypertension During Pregnancy: Chronic Hypertension and Pregnancy (CHAP) Project

Last checked: Nov 19, 2026Latest source record: May 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,408 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,408

Actual

Start

Jun 2015

Primary completion

Apr 1, 2022

Study completion Dec 16, 2022

Sponsor

Lead sponsor
University of Alabama at BirminghamAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Columbia University; Drexel University College of Medicine; Rutgers, The State University of New Jersey; Lehigh Valley Hospital; Saint Peters University Hospital; Christiana Care Health Services; Washington University School of Medicine; Duke University; University of Texas Southwestern Medical Center; The University of Texas Health Science Center, Houston; Stanford University; University of Pennsylvania; The University of Texas Medical Branch, Galveston; University of Utah; Intermountain Health Care, Inc.; University of California, San Francisco; Johns Hopkins University; University of Pittsburgh; Ochsner Health System; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI); WakeMed Health and Hospitals; San Francisco General Hospital; McKay-Dee Hospital; Winthrop University Hospital; New York Hospital Queens; Latter Day Saints Hospital; Lyndon B Johnson General Hospital; Virtua Medical Group; Duke Regional Hospital; Utah Valley Regional Medical Center; Northwestern University; Women and Infants Hospital of Rhode Island; Baylor College of Medicine; Case Western/Metro Health; Ohio State University; University of Iowa; University of California, San Diego; Indiana University; Meriter Foundation; Weill Medical College of Cornell University; University of Oklahoma; Medical University of South Carolina; Beaumont Hospital; University of Colorado, Denver; University of Kansas Medical Center; Denver Health and Hospital Authority; Gundersen Health System; Wake Forest University Health Sciences; Oregon Health and Science University; Medical College of Wisconsin; Temple University; New Jersey Medical School; University of South Alabama; Vanderbilt University; University of Arkansas; Emory University; St. Luke's Hospital and Health Network, Pennsylvania; The Cleveland Clinic; University of Tennessee; TriHealth Inc.; Tulane University; Yale University; Arrowhead Regional Medical Center; Geisinger Clinic; Miami Valley Hospital
First posted
Nov 24, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (\<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.

Conditions

  • Hypertension

Interventions

  • Anti-hypertensive therapyDrug

    1st line anti-hypertensive (Labetalol or Nifedipine ER) started; escalate to maximum dose and a preferred 2nd line medication if needed (nifedipine ER or Labetalol)

  • No anti-hypertensive therapy (unless BP is severe)Other

    Treatment will not be started if blood pressure remains \<160/105; for blood pressure ≥160/105, treatment with labetalol or Nifedipine ER will be initiated and maintained at lowest dose needed to keep blood pressure under 160/105.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Adverse Perinatal OutcomeTime frame: Up to 2 weeks postpartum for preeclampsia or 90 days for neonatal death
  2. Small for Gestational Age (Safety)Time frame: Until delivery

Locations

72 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham, Clinical Coordinating Center

    Birmingham, Alabama

  • University of Alabama at Birmingham, Data Coordinating Center

    Birmingham, Alabama

  • University of South Alabama

    Mobile, Alabama

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Arrowhead Regional Medical Center

    Colton, California

  • University of California, San Diego

    San Diego, California

  • General Hospital of San Francisco

    San Francisco, California

  • University of California San Francisco

    San Francisco, California

  • Stanford University

    Stanford, California

  • University of Colorado

    Boulder, Colorado

  • Denver Health

    Denver, Colorado

  • Yale University

    New Haven, Connecticut

  • Christiana Care Health Services

    Newark, Delaware

  • University of South Florida

    Tampa, Florida

  • Emory University

    Atlanta, Georgia

  • Northwestern

    Evanston, Illinois

  • Indiana University

    Bloomington, Indiana

  • University of Iowa

    Iowa City, Iowa

  • University of Kansas Medical Center

    Lawrence, Kansas

  • University of Kentucky

    Lexington, Kentucky

  • Tulane

    New Orleans, Louisiana

  • Ochsner Health System/Medical Center

    New Orleans, Louisiana

  • Beaumont Hospital

    Royal Oak, Michigan

  • University of Mississippi Medical College

    Jackson, Mississippi

  • Washington University

    St Louis, Missouri

  • Robert Wood Johnson Medical School

    New Brunswick, New Jersey

  • St. Peters University Hospital

    New Brunswick, New Jersey

  • New Jersey Medical School

    Newark, New Jersey

  • Virtua Medical Group

    Sewell, New Jersey

  • New York Presbyterian Queens

    Flushing, New York

  • Winthrop University Hospital

    Mineola, New York

  • Columbia University

    New York, New York

  • Weill Cornell

    New York, New York

  • University of North Carolina

    Chapel Hill, North Carolina

  • Duke Regional Medical Center

    Durham, North Carolina

  • Duke University

    Durham, North Carolina

  • WakeMed

    Raleigh, North Carolina

  • TriHealth, Inc

    Cincinnati, Ohio

  • Case Western/Metro Health

    Cleveland, Ohio

  • Cleveland Clinic Fairview

    Cleveland, Ohio

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.